Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-25

Clinical Trial Update: Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating mitochondrial dysfunction associated with atypical antipsychotics in schizophrenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED